The activation of the LGALS9-HAVCR2 signal can co-express with PD-1 in tumor-infiltrating immune cells, and cooperate to mediate effector T cell exhaustion and dysfunction (Bi et al., 2021; Dixon et al., 2021). The gene discussed is HAVCR2; the disease is neoplasm.